Zidovudine in primary Sjogren's syndrome

Rheumatology

Volumn 38, Issue 9, 1999, Pages 814-817

  Steinfeld, S D ^a   Demols, P ^a   Van Vooren, J P ^a   Cogan, E ^a   Appelboom, T ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Retrovirus; Sjogren's syndrome; Zidovudine

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DRUG TOLERABILITY; DRY EYE; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; SJOEGREN SYNDROME; SKIN SENSITIVITY; VISION; XEROSTOMIA; CLINICAL TRIAL; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ANTI-HIV AGENTS; DRY EYE SYNDROMES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; TREATMENT OUTCOME; XEROSTOMIA; ZIDOVUDINE;

EID: 0033191424     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.9.814     Document Type: Article

References (28)

1. Talal N, Moutsopoulos HM, Kassan S (eds) Sjögren's syndrome: Clinical and immunological aspects. Berlin: Springer-Verlag, 1987.
2. Garry RF, Krieg AM, Cheevers WP et al. Retroviruses and their role in chronic inflammatory diseases and autoimmunity. New York: Plenum Press, 1995.
3. Mason AL, Xu L, Guo L et al. Detection of retroviral antibodies in primary cirrhosis and other idiopathic biliary disorders. Lancet 1998;351:1620-4.
4. Talal N, Dauphinee MJ, Dang H, Alexander SS, Hart DJ, Garry RF. Detection of serum antibodies to retroviral proteins in patients with Primary Sjögren's syndrome (auto-immune exocrinopathy). Arthritis Rheum 1990;33: 774-81.
5. Brookes SM, Pandofilno YA, Mitchell TJ et al. The immune response to and expression of cross-reactive retroviral GAG sequences in autoimmune disease. Br J Rheumatol 1992;31:735-42.
6. Terada K, Katamine S, Eguchi K et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet 1994;344:1116-9.
7. Shattles WG, Brookes SM, Venables PJW, Clark DA, Maini RN. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome. Clin Exp Immunol 1992;89:46-51.
8. Couderc LJ, D'Agay MF, Danon F, Harzic M, Brocheniou C, Cauvel JP. Sicca complex and infection with Human Immunodeficiency Virus. Arch Intern Med 1987;147:898-901.
9. Tamiya S, Matsuoka M, Etoh K et al. Two types of defective Human T-Lymphotropic Virus Type I provirus in adult T-cell leukemia. Blood 1996;88:3065-73.
10. Eguchi K, Matsuoka N, Ida H el al. Primary Sjögren's syndrome with antibodies to HTLV-1: Clinical and laboratory features. Ann Rheum Dis 1988;51:769-76.
11. Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Lou-Zhang H. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990;220:1127-9.
12. Yamano S, Renard JN, Mizuno F, Uchida Y, Higashiyama H, Sakurai H et al. Retrovirus in salivary glands from patients with Sjögren's syndrome. J Clin Pathol 1997;50:223-30.
13. Griffiths DJ, Venables PJW, Weiss RA, Boyd MT. A novel exogenous retrovirus sequence identified in humans. J Virol 1997;71:2866-72.
14. Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 Tax transgenic mice. Nature 1989;341:72-4.
15. Mitsuya H, Weinhold KJ, Furman PA el al. 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985;82:7096-100.
16. Itescu S, Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum Dis Clin 1992;18:683-97.
17. Moutsopoulos HM. Sjögren's Syndrome therapy: Future directions. J Rheumatol 1997;24(suppl. 50):33-4.
18. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36:340-7.
19. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
20. Kinloch-De Loes S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A et al. A controlled trial of zidovudine in primary immunodeficiency virus infection. N Engl J Med 1995;333:408-13.
21. Greenspan J, Daniels T, Talal N, Sylvester R. The histopathology of Sjögren's syndrome in labial biopsies. Oral Surg 1974;37:217-30.
22. Drosos AA, Skopouli FN, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM. Cyclosporin A in primary Sjögren's syndrome: a double blind study. Ann Rheum Dis 1986;45:732-5.
23. Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM. Methotrexate in primary Sjögren's syndrome. Clin Exp Rheumatol 1996;14:555-8.
24. Price EJ, Rigby SP, Clancy U, Venables PJW. A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndrome. Arthritis Rheum 1998;25:896-9.
25. Gill PS, Harrington W Jr, Kaplan MH et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995; 32:1744-8.
26. Silvestri G, Munoz-Calleja C, Bagnarelli P, Piedimonte G, Clementi M, Montroni M. Early increase of CD4+CD45RA and CD4+CD95-cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Clin Exp Immunol 1998;111:3-11.
27. Fox RI, Chan E, Benton L, Fong S, Friedlander M, Howell FV. Treatment of primary Sjögren's syndrome with hydroxychloroquine. Am J Med 1988;85:62-7.
28. Kruize AA, Hene RJ, Kallenberg CG et al. Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 1993;52:360-4.